Trevi Therapeutics, Inc. (TRVI) Marketable Securities, Current USD 2022 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Trevi Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from 2022 to 2024.
  • Trevi Therapeutics, Inc. Marketable Securities, Current for the quarter ending March 31, 2024 was $59 M, a 40.8% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $59 M -$40.6 M -40.8% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $50.6 M -$57.3 M -53.1% Dec 31, 2023 10-Q 2024-05-07
Q3 2023 $62.9 M +$3.87 M +6.56% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $80.4 M +$27.2 M +51.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $99.6 M Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $108 M Dec 31, 2022 10-K 2024-03-20
Q3 2022 $59 M Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $53.2 M Jun 30, 2022 10-Q 2022-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.